| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.12 | 0.4 |